Massimo Iavarone

7.7k total citations
130 papers, 3.5k citations indexed

About

Massimo Iavarone is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Massimo Iavarone has authored 130 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Hepatology, 79 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Massimo Iavarone's work include Liver Disease Diagnosis and Treatment (65 papers), Hepatocellular Carcinoma Treatment and Prognosis (63 papers) and Hepatitis B Virus Studies (40 papers). Massimo Iavarone is often cited by papers focused on Liver Disease Diagnosis and Treatment (65 papers), Hepatocellular Carcinoma Treatment and Prognosis (63 papers) and Hepatitis B Virus Studies (40 papers). Massimo Iavarone collaborates with scholars based in Italy, United States and Spain. Massimo Iavarone's co-authors include Pietro Lampertico, Angelo Sangiovanni, Massimo Colombo, Mauro Viganò, M. Colombo, E. Manenti, Giuseppe Cabibbo, Fabio Piscaglia, Massimo Colombo and G. Lunghi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Massimo Iavarone

120 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Iavarone Italy 30 2.7k 2.2k 493 454 420 130 3.5k
Giuseppe Cabibbo Italy 32 2.8k 1.0× 2.1k 0.9× 553 1.1× 529 1.2× 388 0.9× 128 3.7k
M. Colombo Italy 23 2.7k 1.0× 2.1k 0.9× 352 0.7× 413 0.9× 321 0.8× 70 3.4k
Jeong Won Jang South Korea 35 3.1k 1.1× 2.3k 1.1× 656 1.3× 851 1.9× 554 1.3× 219 4.4k
Yung Sang Lee South Korea 35 3.9k 1.4× 3.2k 1.5× 822 1.7× 472 1.0× 322 0.8× 113 4.8k
Joon Hyeok Lee South Korea 31 2.8k 1.0× 2.3k 1.1× 899 1.8× 780 1.7× 247 0.6× 153 4.0k
Sherrie Bhoori Italy 25 2.6k 0.9× 1.7k 0.8× 1.2k 2.3× 694 1.5× 576 1.4× 58 3.8k
Carlos Rodríguez de Lope Spain 19 3.2k 1.2× 1.9k 0.9× 984 2.0× 561 1.2× 390 0.9× 38 4.0k
Roniel Cabrera United States 26 1.6k 0.6× 1.1k 0.5× 437 0.9× 687 1.5× 499 1.2× 73 3.0k
Cheng‐Yuan Hsia Taiwan 31 2.5k 0.9× 1.7k 0.8× 1.1k 2.2× 562 1.2× 303 0.7× 122 3.3k
Kazuomi Ueshima Japan 34 3.4k 1.3× 2.0k 0.9× 765 1.6× 649 1.4× 461 1.1× 156 4.4k

Countries citing papers authored by Massimo Iavarone

Since Specialization
Citations

This map shows the geographic impact of Massimo Iavarone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Iavarone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Iavarone more than expected).

Fields of papers citing papers by Massimo Iavarone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Iavarone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Iavarone. The network helps show where Massimo Iavarone may publish in the future.

Co-authorship network of co-authors of Massimo Iavarone

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Iavarone. A scholar is included among the top collaborators of Massimo Iavarone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Iavarone. Massimo Iavarone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iavarone, Massimo, Massimo Puoti, Hamid Hasson, et al.. (2025). Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study. Liver International. 45(12). e70437–e70437.
2.
Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2024). Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death. Clinical Cancer Research. 31(3). 543–550. 6 indexed citations
3.
Iavarone, Massimo, Barbara Antonelli, Anna Maria Ierardi, et al.. (2024). A modified Charlson Comorbidity Index to improve management of patients with hepatocellular carcinoma: a step towards precision medicine. Digestive and Liver Disease. 56. S81–S81.
4.
Dondossola, Daniele, Giulia Marini, Massimo Iavarone, et al.. (2024). Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on Outcomes. Cancers. 16(5). 1043–1043.
5.
Tabrizian, Parissa, Rebecca Marino, Sherrie Bhoori, et al.. (2024). Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma. JHEP Reports. 7(2). 101246–101246. 6 indexed citations
6.
Iavarone, Massimo, Riccardo Perbellini, Sara Uceda Renteria, et al.. (2024). ASAP score may predict HCC recurrence after complete radiological response to locoregional treatments. Digestive and Liver Disease. 56. S89–S89. 1 indexed citations
7.
Biselli, Maurizio, Massimo Iavarone, Matteo Renzulli, et al.. (2024). Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers. 16(6). 1080–1080. 2 indexed citations
8.
Ierardi, Anna Maria, Alessandro Caruso, Letizia Di Meglio, et al.. (2023). Virtual Treatment Zone From Cone Beam CT Commonly Alters Treatment Plan and Identifies Tumor at Risk for Under-Treatment in US or US Fusion-Guided Microwave Ablation of Liver Tumors. Technology in Cancer Research & Treatment. 22. 2223923172–2223923172.
9.
Gramantieri, Laura, Cristian Bassi, Lucilla D’Abundo, et al.. (2023). Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma. European Journal of Immunology. 54(2). e2350637–e2350637. 5 indexed citations
10.
11.
Giovannini, Catia, Francesco Tovoli, Francesca Fornari, et al.. (2023). Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma. Cancers. 15(6). 1661–1661. 9 indexed citations
12.
Terzi, Eleonora, Massimo Iavarone, Simona Leoni, et al.. (2022). Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5). Cancers. 14(2). 336–336. 11 indexed citations
13.
Tovoli, Francesco, Ingrid Garajová, Fabio Gelsomino, et al.. (2021). Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials. Liver International. 42(2). 458–467. 7 indexed citations
14.
15.
Goossens, Nicolas, Guo J, Ming‐Chao Tsai, et al.. (2015). A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection. Gut. 65(10). 1754–1764. 92 indexed citations
16.
Massironi, Sara, Rosario Rossi, Mirella Fraquelli, et al.. (2013). 722 LIVER STIFFNESS AND HEPATOCELLULAR CARCINOMA: IS IT REALLY USEFUL?. Journal of Hepatology. 58. S293–S293. 2 indexed citations
17.
Hoshida, Yujin, Augusto Villanueva, Angelo Sangiovanni, et al.. (2013). Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis. Gastroenterology. 144(5). 1024–1030. 158 indexed citations
18.
Stroffolini, Tommaso, Franco Trevisani, G. Pinzello, et al.. (2011). Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance. Digestive and Liver Disease. 43(11). 875–80. 27 indexed citations
19.
Iavarone, Massimo, Pietro Lampertico, Mauro Viganò, et al.. (2008). Progressive decline of HBsAg titers in longterm virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B. Hepatology. 48. 1 indexed citations
20.
Lampertico, Pietro, Mauro Viganò, E. Manenti, et al.. (2007). Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients. Gastroenterology. 133(5). 1445–1451. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Cabibbo Breakdown of academic impact, for papers by M. Colombo Breakdown of academic impact, for papers by Jeong Won Jang Breakdown of academic impact, for papers by Yung Sang Lee Breakdown of academic impact, for papers by Joon Hyeok Lee Breakdown of academic impact, for papers by Sherrie Bhoori Breakdown of academic impact, for papers by Carlos Rodríguez de Lope Breakdown of academic impact, for papers by Roniel Cabrera Breakdown of academic impact, for papers by Cheng‐Yuan Hsia Breakdown of academic impact, for papers by Kazuomi Ueshima
Rankless by CCL
2026